| Name | Title | Contact Details |
|---|
Noridian Healthcare Solutions, LLC (Noridian) develops solutions for federal, state and commercial health care programs through a full suite of innovative offerings, including claims processing, medical review, and contact center and provider administrative services. Headquartered in Fargo, N.D. with staff located throughout the nation, Noridian administrates people-first services across all 50 U.S. states. Leveraging its decades of experience, the Noridian team designs and implements customizable, high-quality solutions to eliminate common health care barriers, enabling access to care.
Physical Rehabilitation Network (PRN) was founded in 1991 to assist physical therapists in developing and operating their own practice without carrying the burden of business administration and back office functions. In this capacity our partners can focus on what they do best - providing excellence in patient care! PRN has a fierce commitment to our therapist partners with proven revenue cycle management, personalized human resources, regional business development and contract opportunities. PRN is the most prominent network of independently operated physical & hand rehabilitation centers in the western United States. After starting out in southern California with one practice, PRN presently serves over 120 centers in nine states.
Novasys Health is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
Pelham Parkway Nursing Home is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.